---
figid: PMC8465622__biomolecules-11-01301-g002
figtitle: Repurposing Small Molecules to Target PPARG as New Therapies for Peripheral
  Nerve Injuries
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Candida dubliniensis
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC8465622
filename: biomolecules-11-01301-g002.jpg
figlink: /pmc/articles/PMC8465622/figure/biomolecules-11-01301-f002/
number: F2
caption: PPAR-γ receptor and its effect on downstream pathways that are potential
  targets for drug agents. Including the Rho/ROCK inhibitory pathway which when blocked
  stops growth-cone collapse and encourages neurite outgrowth. Proliferator-activated
  receptor gamma (PPAR-γ), Src homology region 2–containing protein tyrosine phosphatase-2
  (SHP-2), Ras homolog family member A (RhoA), guanosin-5′-triphosphate (GTP), phosphatidylinositol
  4-phosphate-5 kinase (PIP5K), protein kinase N (PKN), Rho-associated kinase (ROCK),
  myosin light chain (MLC), LIM kinase (LIMK) and collapsin response mediator protein
  2 (CRMP2), phosphatase and tensin homolog (PTEN), inositol triphosphate (IP3), inositol
  biphosphate (IP2), serine/threonine protein kinase B (Akt) [].
papertitle: Repurposing Small Molecules to Target PPAR-γ as New Therapies for Peripheral
  Nerve Injuries.
reftext: Melissa L. D. Rayner, et al. Biomolecules. 2021 Sep;11(9):1301.
year: '2021'
doi: 10.3390/biom11091301
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: peripheral nerve injury | drug repurposing | PPAR-γ | small molecules |
  nerve regeneration | Rho/ROCK pathway
automl_pathway: 0.9613297
figid_alias: PMC8465622__F2
figtype: Figure
redirect_from: /figures/PMC8465622__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8465622__biomolecules-11-01301-g002.html
  '@type': Dataset
  description: PPAR-γ receptor and its effect on downstream pathways that are potential
    targets for drug agents. Including the Rho/ROCK inhibitory pathway which when
    blocked stops growth-cone collapse and encourages neurite outgrowth. Proliferator-activated
    receptor gamma (PPAR-γ), Src homology region 2–containing protein tyrosine phosphatase-2
    (SHP-2), Ras homolog family member A (RhoA), guanosin-5′-triphosphate (GTP), phosphatidylinositol
    4-phosphate-5 kinase (PIP5K), protein kinase N (PKN), Rho-associated kinase (ROCK),
    myosin light chain (MLC), LIM kinase (LIMK) and collapsin response mediator protein
    2 (CRMP2), phosphatase and tensin homolog (PTEN), inositol triphosphate (IP3),
    inositol biphosphate (IP2), serine/threonine protein kinase B (Akt) [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIKFYVE
  - PKN1
  - PKN2
  - PKN3
  - RHOA
  - MTG1
  - VAV1
  - VAV2
  - VAV3
  - PTPN11
  - ROCK1
  - ROCK2
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - MLC1
  - LIMK1
  - DPYSL2
  - PTEN
  - IKBKG
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - Pikfyve
  - Pkn1
  - Rhoa
  - Vav1
  - Ptpn11
  - Mlc1
  - Limk1
  - Dpysl2
  - Pten
  - Akt1
  - Gsk3b
  - Pck1
  - sktl
  - PIP5K59B
  - Pkn
  - meng
  - CG4945
  - Rho1
  - Vav
  - csw
  - Rok
  - sqh
  - Mlc2
  - Akt
  - sgg
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
---
